Skip to main content
SpringerLink
Log in

Role of Activin A in the Pathogenesis of Endothelial Cell Dysfunction in Preeclampsia

  • Protocol
  • First Online:
Preeclampsia

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1710))

Abstract

This chapter describes the methodologies which may be used in evaluating in vitro endothelial cell dysfunction in preeclampsia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Lyall F, Greer IA (1994) Pre-eclampsia: a multifaceted vascular disorder of pregnancy. J Hypertens 12(12):1339–1345

    Article  CAS  PubMed  Google Scholar 

  2. Roberts JM, Redman CW (1993) Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341(8858):1447–1451

    Article  CAS  PubMed  Google Scholar 

  3. Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308(5728):1592–1594

    Article  CAS  PubMed  Google Scholar 

  4. Roberts JM, Hubel CA (2009) The two stage model of preeclampsia: variations on the theme. Placenta 30(Suppl A):S32–S37

    Article  PubMed  Google Scholar 

  5. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111(5):649–658

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350(7):672–683

    Article  CAS  PubMed  Google Scholar 

  7. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355(10):992–1005

    Article  CAS  PubMed  Google Scholar 

  8. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D’Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12(6):642–649

    Article  CAS  PubMed  Google Scholar 

  9. Steinberg G, Khankin EV, Karumanchi SA (2009) Angiogenic factors and preeclampsia. Thromb Res 123(Suppl 2):S93–S99

    Article  PubMed  Google Scholar 

  10. Fenton C, Hobson SR, Wallace EM, Lim R (2014) Future therapies for pre-eclampsia: beyond treading water. Aust N Z J Obstet Gynaecol 54:3

    Article  PubMed  Google Scholar 

  11. Petraglia F (1997) Inhibin, activin and follistatin in the human placenta--a new family of regulatory proteins. Placenta 18(1):3–8

    Article  CAS  PubMed  Google Scholar 

  12. Fowler PA, Evans LW, Groome NP, Templeton A, Knight PG (1998) A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy. Hum Reprod 13(12):3530–3536

    Article  CAS  PubMed  Google Scholar 

  13. Schneider-Kolsky M, D’Antona D, Evans LW, Taylor N, O’Connor A, Groome NP, de Kretser D, Wallace EM (2000) Maternal serum total activin A and follistatin in pregnancy and parturition. BJOG 107(8):995–1000

    Article  CAS  PubMed  Google Scholar 

  14. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL (1997) Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet 349(9061):1285–1288

    Article  CAS  PubMed  Google Scholar 

  15. Schneider-Kolsky M, Manuelpillai U, Gargett C, Wallace EM (2001) Activin betaA-subunit and activin receptors in human myometrium at term and during labour. BJOG 108(8):869–874

    CAS  PubMed  Google Scholar 

  16. Manuelpillai U, Schneider-Kolsky M, Dole A, Wallace EM (2001) Activin A and activin receptors in gestational tissue from preeclamptic pregnancies. J Endocrinol 171(1):57–64

    Article  CAS  PubMed  Google Scholar 

  17. Mandang S, Manuelpillai U, Wallace EM (2007) Oxidative stress increases placental and endothelial cell activin A secretion. J Endocrinol 192(3):485–493

    Article  CAS  PubMed  Google Scholar 

  18. Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J, Ledger W, Groome N, Redman CW (2000) Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 15(7):1640–1645

    Article  CAS  PubMed  Google Scholar 

  19. Schneider-Kolsky ME, Manuelpillai U, Waldron K, Dole A, Wallace EM (2002) The distribution of activin and activin receptors in gestational tissues across human pregnancy and during labour. Placenta 23(4):294–302

    Article  CAS  PubMed  Google Scholar 

  20. McCarthy SA, Bicknell R (1993) Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem 268(31):23066–23071

    CAS  PubMed  Google Scholar 

  21. Lim R, Acharya R, Delpachitra P, Hobson S, Sobey CG, Drummond GR, Wallace EM (2015) Activin and NADPH-oxidase in preeclampsia: insights from in vitro and murine studies. Am J Obstet Gynecol 212:86.e1

    Article  CAS  Google Scholar 

  22. Gurusinghe S, Wallace EM, Lim R (2014) The relationship between Activin A and anti-angiogenic factors in the development of pre-eclampsia. Pregnancy Hypertens 4(1):3–6

    Article  PubMed  Google Scholar 

  23. Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115(10):1285–1295

    PubMed  Google Scholar 

  24. Signore C, Mills JL, Qian C, Yu K, Lam C, Epstein FH, Karumanchi SA, Levine RJ (2006) Circulating angiogenic factors and placental abruption. Obstet Gynecol 108(2):338–344

    Article  CAS  PubMed  Google Scholar 

  25. Nova A, Sibai BM, Barton JR, Mercer BM, Mitchell MD (1991) Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 165(3):724–727

    Article  CAS  PubMed  Google Scholar 

  26. Wang Y, Gu Y, Granger DN, Roberts JM, Alexander JS (2002) Endothelial junctional protein redistribution and increased monolayer permeability in human umbilical vein endothelial cells isolated during preeclampsia. Am J Obstet Gynecol 186(2):214–220

    Article  CAS  PubMed  Google Scholar 

  27. Blann AD, Taberner DA (1995) A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 90(2):244–248

    Article  CAS  PubMed  Google Scholar 

  28. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr (1995) Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 92(9):2426–2431

    Article  CAS  PubMed  Google Scholar 

  29. Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52(11):2745–2756

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408

    Article  CAS  PubMed  Google Scholar 

  31. O’Connor AE, McFarlane JR, Hayward S, Yohkaichiya T, Groome NP, de Kretser DM (1999) Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study. Hum Reprod 14(3):827–832

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Maternal Fetal Medicine Unit, Department of Obstetrics & Gynaecology, Monash Medical Centre, Monash Health & Monash University, 246 Clayton Road, Clayton, VIC, 3168, Australia

    Sebastian R. Hobson, Rebecca Lim, Joanne C. Mockler, Seshini Gurusinghe & Euan M. Wallace

Authors
  1. Sebastian R. Hobson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rebecca Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joanne C. Mockler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seshini Gurusinghe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Euan M. Wallace
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sebastian R. Hobson .

Editor information

Editors and Affiliations

  1. Monash Medical Centre, Monash University, Clayton, Victoria, Australia

    Padma Murthi

  2. INRS-Institut Armand-Frappier, Laval, Québec, Canada

    Cathy Vaillancourt

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Hobson, S.R., Lim, R., Mockler, J.C., Gurusinghe, S., Wallace, E.M. (2018). Role of Activin A in the Pathogenesis of Endothelial Cell Dysfunction in Preeclampsia. In: Murthi, P., Vaillancourt, C. (eds) Preeclampsia . Methods in Molecular Biology, vol 1710. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7498-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7498-6_4

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7497-9

  • Online ISBN: 978-1-4939-7498-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation